Sugammadex-Associated Hypotension, Bradycardia, Asystole, and Death

On December 16, 2015, the Food and Drug Administration (FDA) in the United States approved sugammadex (Bridion, Merck and Co), a modified gamma-cyclodextrin, to be used as a reversal agent. It is a first and unique selective nondepolarizing steroidal muscle relaxant (NDSMR) binding agent with a grea...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirza, Kazim, Landoski, Kathryn, Thakar, Dilip, Heir-Singh, Jagtar, Jackson, Timothy, Kassab, Cynthia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303763/
https://www.ncbi.nlm.nih.gov/pubmed/32566314
http://dx.doi.org/10.1155/2020/8767195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303763/
https://www.ncbi.nlm.nih.gov/pubmed/32566314
http://dx.doi.org/10.1155/2020/8767195

Ejemplares similares